Meta-analysis in Post-marketing Surveillances for SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to integrate the post-marketing surveillances data (Specified
use-results surveys on long-term treatment) of the 6 SGLT2 inhibitors approved or applied in
Japan and to evaluate the safety and efficacy of long-term use of each under actual clinical
practice conditions.
In each post-marketing surveillance, 3000 patients who complete a 3 years treatment are
enrolled. A total of 18000 patients are assessed in the meta-analysis.